A detailed history of Mach 1 Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Mach 1 Financial Group, LLC holds 1,079 shares of ABBV stock, worth $189,450. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,079
Previous 1,243 13.19%
Holding current value
$189,450
Previous $213,000 -0.0%
% of portfolio
0.15%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$163.84 - $199.33 $26,869 - $32,690
-164 Reduced 13.19%
1,079 $213,000
Q2 2024

Jul 30, 2024

SELL
$154.79 - $180.76 $37,304 - $43,563
-241 Reduced 16.24%
1,243 $213,000
Q1 2024

May 10, 2024

SELL
$159.82 - $182.1 $2.77 Million - $3.15 Million
-17,314 Reduced 92.11%
1,484 $270,000
Q4 2023

Feb 05, 2024

BUY
$137.6 - $154.97 $576,131 - $648,859
4,187 Added 28.66%
18,798 $2.91 Million
Q3 2023

Oct 17, 2023

BUY
$133.59 - $154.65 $11,221 - $12,990
84 Added 0.58%
14,611 $2.18 Million
Q2 2023

Jul 28, 2023

BUY
$132.51 - $164.9 $1.83 Million - $2.27 Million
13,789 Added 1868.43%
14,527 $1.96 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $1.55 Million - $1.78 Million
-10,704 Reduced 93.55%
738 $117,000
Q4 2022

Feb 02, 2023

BUY
$138.31 - $165.87 $1.45 Million - $1.74 Million
10,471 Added 1078.37%
11,442 $1.85 Million
Q3 2022

Nov 08, 2022

BUY
$134.21 - $153.93 $5,368 - $6,157
40 Added 4.3%
971 $130,000
Q2 2022

Aug 04, 2022

BUY
$137.62 - $174.96 $128,124 - $162,887
931 New
931 $142,000
Q1 2022

May 06, 2022

SELL
$131.98 - $163.75 $2,375 - $2,947
-18 Closed
0 $0
Q4 2021

Feb 11, 2022

BUY
$107.43 - $135.93 $1,933 - $2,446
18 New
18 $2,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mach 1 Financial Group, LLC Portfolio

Follow Mach 1 Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mach 1 Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mach 1 Financial Group, LLC with notifications on news.